BGLAP and type 2 diabetes mellitus: A meta-analysis of 66 studies found that compared to controls, individuals with T1DM and T2DM had substantially higher levels of sclerostin and significantly lower levels of osteocalcin and C-terminal cross-linking telopeptides.